CAS: | 1320288-19-4 | |
分子式: | C37H61N7O2 | |
分子量: | 635.9299999999999 | |
英文名称: |
| |
用途: | UNC 0631是G9a抑制剂,IC50为4nM。 |
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||
U883252 | MACKLIN | UNC 0631 | ≥98% | 781元/5mg; 1357元/10mg; | 展开 | ||||||||||||||||||||||
储存:2-8℃ | |||||||||||||||||||||||||||
1578395 | J&K | UNC 0631 | 98%, 是G9a抑制剂, IC50为4nM | 1017元/5MG; 1767元/10MG; | 展开 | ||||||||||||||||||||||
基本信息
产品描述 UNC 0631 is a potent G9a inhibitor with IC50 value of 4 nM. IC50 value: 4 nM [1] Target: G9a UNC 0631, which had high in vitro potency versus G9a and improved lipophilicity, was highly potent (IC50 < 0.06 μM) in reducing H3K9me2 levels in MDA-MB-231 cells and had low cell toxicity. In particular, compounds 7 was more potent than compound 5 and had a similar tox/function ratio in MDAMB-231 cells. UNC 0631 showed excellent separation of functional potency versus cell toxicity in MDA-MB-231 cells, thecompound was further evaluated in a variety of cell lines to characterize it's cellular potency and cell toxicity. UNC 0631 had excellent tox/function ratios in these cell lines. 靶点(IC50 & Targe) G9a 参考文献 [1]. Liu F, et al. Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J Med Chem. 2011 Sep 8;54(17):6139-50. 安全信息
|